Evidence map›Paper›PMID 27027343›Full record

ArticleOncotarget2016

Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells.

Wenwen Qi, Mingjuan Sun, Xiangnan Kong, Yaming Li, Xiaolong Wang, Shangge Lv, Xia Ding, Sumei Gao, Jinjing Cun, Chang Cai and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Efficacy of Huaier granule in patients with breast cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Article
  12. Cancer management and research · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Wenwen QiDepartment of Breast Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Mingjuan SunShandong Cancer Hospital and Institute, Jinan, P.R. China.
Xiangnan KongLaboratory Medicine Center, Qilu Hospital of Shandong University, Qingdao, P.R. China.
Yaming LiDepartment of Breast Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Xiaolong WangDepartment of Breast Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Shangge LvDepartment of Breast Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Xia DingDepartment of Oncology, Qilu Hospital, Shandong University, Jinan, P.R. China.
Sumei GaoDepartment of Breast Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Jinjing CunDepartment of Breast Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Chang CaiDepartment of Breast Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Xiaoting WangDepartment of Breast Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Junfei ChenDepartment of Breast Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Aijun YinDepartment of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, P.R. China.
Qifeng YangDepartment of Breast Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Qilu Hospital of Shandong University · CNShandong First Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tamoxifen (TAM) is the most widely used endocrine therapy for estrogen receptor (ER)-positive breast cancer patients, but side effects and the gradual development of insensitivity limit its application. We investigated whether Huaier extract, a traditional Chinese medicine, in combination with TAM would improve treatment efficacy in ER-positive breast cancers. MTT, colony formation, and invasion and migration assays revealed that the combined treatment had stronger anticancer effects than either treatment alone. Huaier extract enhanced TAM-induced autophagy, apoptosis, and G0/G1 cell cycle arrest, as measured by acidic vesicular organelle (AVO) staining, TUNEL, flow cytometry, and western blot. Additionally, combined treatment inhibited tumorigenesis and metastasis by suppressing the AKT/mTOR signaling pathway. Huaier extract also enhanced the inhibitory effects of TAM on tumor growth in vivo in a xenograft mouse model. These results show that Huaier extract synergizes with TAM to induce autophagy and apoptosis in ER-positive breast cancer cells by suppressing the AKT/mTOR pathway.

Indexed as

Drug SynergismAnimalsAntineoplastic Agents, HormonalApoptosisAutophagyBiological ProductsBreast NeoplasmsCell CycleCell MovementCell ProliferationComplex MixturesDrug Therapy, CombinationFemaleHumansMiceMice, Inbred BALB CAntineoplastic Agents, HormonalBiological ProductsComplex MixtureshuaierReceptors, EstrogenTamoxifenapoptosisautophagyER-positive breast cancerHuaier extracttamoxifen

Identifiers

PMID27027343
PMCPMC5041960
OpenAlexW2337436866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.